Overview

Compare the Effect on Cognitive Functioning of Two Formulations of Seroquel, Seroquel XR and IR in Patients With Stable Schizophrenia

Status:
Completed

Trial end date:
2011-08-01

Target enrollment:

Participant gender:

Summary

This will be a phase IV 20 -32 day prospective, double blind, double-dummy, randomised crossover study that will evaluate the effect of quetiapine XR and quetiapine IR on cognitive performance in patients with schizophrenia stabilized on a single antipsychotic medication.

Phase:

Phase 4

Details

Lead Sponsor:

AstraZeneca

Treatments:

Quetiapine Fumarate